Monash IVF Group Limited
Monash IVF Group Limited Fundamental Analysis
Monash IVF Group Limited (MVF.AX) shows weak financial fundamentals with a PE ratio of 16.97, profit margin of 5.63%, and ROE of 6.06%. The company generates $0.3B in annual revenue with moderate year-over-year growth of 6.65%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 29.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MVF.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakMVF.AX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentMVF.AX trades at attractive valuation levels.
Growth Score
ModerateMVF.AX shows steady but slowing expansion.
Financial Health Score
WeakMVF.AX carries high financial risk with limited liquidity.
Profitability Score
WeakMVF.AX struggles to sustain strong margins.
Key Financial Metrics
Is MVF.AX Expensive or Cheap?
P/E Ratio
MVF.AX trades at 16.97 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, MVF.AX's PEG of -0.44 indicates potential undervaluation.
Price to Book
The market values Monash IVF Group Limited at 1.01 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.61 times EBITDA. This is generally considered low.
How Well Does MVF.AX Make Money?
Net Profit Margin
For every $100 in sales, Monash IVF Group Limited keeps $5.63 as profit after all expenses.
Operating Margin
Core operations generate 11.33 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.06 in profit for every $100 of shareholder equity.
ROA
Monash IVF Group Limited generates $2.97 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Monash IVF Group Limited generates limited operating cash flow of $23.21M, signaling weaker underlying cash strength.
Free Cash Flow
Monash IVF Group Limited produces free cash flow of $9.23M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.02 in free cash annually.
FCF Yield
MVF.AX converts 3.59% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.97
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.44
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.01
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.95
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.11
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.82
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.07
vs 25 benchmark
How MVF.AX Stacks Against Its Sector Peers
| Metric | MVF.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.97 | 28.45 | Better (Cheaper) |
| ROE | 6.06% | 763.00% | Weak |
| Net Margin | 5.63% | -45265.00% (disorted) | Weak |
| Debt/Equity | 1.11 | 0.34 | Weak (High Leverage) |
| Current Ratio | 0.82 | 2795.60 | Weak Liquidity |
| ROA | 2.97% | -16588.00% (disorted) | Weak |
MVF.AX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Monash IVF Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
56.20%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
78.15%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-59.39%
Industry Style: Defensive, Growth, Innovation
Declining